Eurofins Discovery
September 8, 2026 – Eurofins Discovery proudly celebrates its 2025 innovators, recognizing outstanding team members and teams for their exceptional contributions to scientific advancement and business innovation. This year’s Innovation Award winners, along with all participants in the company’s annual innovation program, exemplify the Eurofins commitment to fostering a culture of creativity, entrepreneurship, and continuous improvement.
Team member Alexander Clifford, Scientist III R&D, has been recognized with the Eurofins Discovery Scientific Innovation Award for his project, Development of a Novel Functional Cell-Based Targeted Protein Degradation Assay Platform for High-Throughput Screening of Heterobifunctional Degraders and Molecular Glues.
Clifford’s project was selected as a winning innovation in recognition of its exceptional impact on scientific capability, operational excellence, and commercial growth within the rapidly expanding field of Targeted Protein Degradation (TPD).
The groundbreaking assay platform strengthens Eurofins Discovery’s position in the TPD market by providing a scalable, high-throughput, and cost-efficient screening solution. The platform enables the evaluation of key degradation parameters, including DC501 and Dmax2, across a broad range of targets for both heterobifunctional degraders and molecular glues. By expanding screening capabilities and improving efficiency, the innovation delivers significant value to customers while advancing Eurofins Discovery’s scientific leadership in this emerging area of drug discovery.
Team members Carol Austin, Senior Director Drug Discovery; Clara Da Ros, Marketing Assistant; Allison Kinnucan, Marketing Manager; and Céline Legros, Partnership Director, have been recognized as recipients of the Eurofins Discovery Business Improvement Award for their collaborative project, Discovery & Beyond: Expert Perspectives.
The team’s initiative was selected as a winning project in recognition of its outstanding contribution to enhancing Eurofins Discovery’s visibility, strengthening its scientific leadership, and increasing customer engagement. Through the development of high-value, insight-driven video content, Discovery & Beyond: Expert Perspectives provides drug discovery researchers and organizations with educational and informative resources designed to inspire innovation and advance scientific understanding.
By showcasing expert perspectives, emerging industry trends, and Eurofins Discovery’s core capabilities and solutions, the series reinforces the company’s position as a trusted partner in drug discovery.
These award winners reflect Eurofins Discovery’s commitment to embedding innovation across both scientific and business operations, resulting in impactful solutions that empower our teams and deliver value to customers around the world.

Aida Yodites, Director, Marketing Communications
aida.yodites@discovery.eurofinsus.com
Eurofins Discovery supports drug discovery research with over 23,000 products and services developed in 40+ years of industry leadership. Benefit from the strength of our solutions that revolutionize your drug discovery.
1 Half-maximal degradation concentration for a given degrader compound
2 Maximum percentage of protein degradation for a given degrader compound